Literature DB >> 26004568

Deaths following vaccination: What does the evidence show?

Elaine R Miller1, Pedro L Moro2, Maria Cano2, Tom T Shimabukuro2.   

Abstract

Vaccines are rigorously tested and monitored and are among the safest medical products we use. Millions of vaccinations are given to children and adults in the United States each year. Serious adverse reactions are rare. However, because of the high volume of use, coincidental adverse events including deaths, that are temporally associated with vaccination, do occur. When death occurs shortly following vaccination, loved ones and others might naturally question whether it was related to vaccination. A large body of evidence supports the safety of vaccines, and multiple studies and scientific reviews have found no association between vaccination and deaths except in rare cases. During the US multi-state measles outbreak of 2014-2015, unsubstantiated claims of deaths caused by measles, mumps, and rubella (MMR) vaccine began circulating on the Internet, prompting responses by public health officials to address common misinterpretations and misuses of vaccine safety surveillance data, particularly around spontaneous reports submitted to the US Vaccine Adverse Event Reporting System (VAERS). We summarize epidemiologic data on deaths following vaccination, including examples where reasonable scientific evidence exists to support that vaccination caused or contributed to deaths. Rare cases where a known or plausible theoretical risk of death following vaccination exists include anaphylaxis, vaccine-strain systemic infection after administration of live vaccines to severely immunocompromised persons, intussusception after rotavirus vaccine, Guillain-Barré syndrome after inactivated influenza vaccine, fall-related injuries associated with syncope after vaccination, yellow fever vaccine-associated viscerotropic disease or associated neurologic disease, serious complications from smallpox vaccine including eczema vaccinatum, progressive vaccinia, postvaccinal encephalitis, myocarditis, and dilated cardiomyopathy, and vaccine-associated paralytic poliomyelitis from oral poliovirus vaccine. However, making general assumptions and drawing conclusions about vaccinations causing deaths based on spontaneous reports to VAERS - some of which might be anecdotal or second-hand - or from case reports in the media, is not a scientifically valid practice. Published by Elsevier Ltd.

Entities:  

Keywords:  Adverse events; Death; Immunization; Vaccination; Vaccine safety

Mesh:

Year:  2015        PMID: 26004568      PMCID: PMC4599698          DOI: 10.1016/j.vaccine.2015.05.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  52 in total

1.  Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-09-03       Impact factor: 17.586

Review 2.  Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

Authors:  Frederick Varricchio; John Iskander; Frank Destefano; Robert Ball; Robert Pless; M Miles Braun; Robert T Chen
Journal:  Pediatr Infect Dis J       Date:  2004-04       Impact factor: 2.129

3.  Intussusception among infants given an oral rotavirus vaccine.

Authors:  T V Murphy; P M Gargiullo; M S Massoudi; D B Nelson; A O Jumaan; C A Okoro; L R Zanardi; S Setia; E Fair; C W LeBaron; M Wharton; J R Livengood; J R Livingood
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

4.  Measles inclusion-body encephalitis caused by the vaccine strain of measles virus.

Authors:  A Bitnun; P Shannon; A Durward; P A Rota; W J Bellini; C Graham; E Wang; E L Ford-Jones; P Cox; L Becker; M Fearon; M Petric; R Tellier
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

Review 5.  Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.

Authors:  P M Strebel; R W Sutter; S L Cochi; R J Biellik; E W Brink; O M Kew; M A Pallansch; W A Orenstein; A R Hinman
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

6.  Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.

Authors:  L R Zanardi; P Haber; G T Mootrey; M T Niu; M Wharton
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

7.  Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Authors:  Melinda Wharton; Raymond A Strikas; Rafael Harpaz; Lisa D Rotz; Benjamin Schwartz; Christine G Casey; Michele L Pearson; Larry J Anderson
Journal:  MMWR Recomm Rep       Date:  2003-04-04

8.  The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997.

Authors:  L E Silvers; S S Ellenberg; R P Wise; F E Varricchio; G T Mootrey; M E Salive
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Jun-Jul       Impact factor: 2.890

9.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors:  L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897

10.  Risk of anaphylaxis after vaccination of children and adolescents.

Authors:  Kari Bohlke; Robert L Davis; S M Marcy; M M Braun; Frank DeStefano; Steven B Black; John P Mullooly; Robert S Thompson
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

View more
  19 in total

1.  Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults.

Authors:  Natalie L McCarthy; Julianne Gee; Lakshmi Sukumaran; Eric Weintraub; Jonathan Duffy; Elyse O Kharbanda; Roger Baxter; Stephanie Irving; Jennifer King; Matthew F Daley; Rulin Hechter; Michael M McNeil
Journal:  Pediatrics       Date:  2016-02-01       Impact factor: 7.124

2.  Raising Rates of Childhood Vaccination: The Trade-off Between Coercion and Trust.

Authors:  Bridget Haire; Paul Komesaroff; Rose Leontini; C Raina MacIntyre
Journal:  J Bioeth Inq       Date:  2018-03-01       Impact factor: 1.352

3.  Spontaneous Myocarditis in Mice Predisposed to Autoimmune Disease: Including Vaccination-Induced Onset.

Authors:  Takuma Hayashi; Motoki Ichikawa; Ikuo Konishi
Journal:  Biomedicines       Date:  2022-06-18

Review 4.  Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.

Authors:  Kiran Teresa Thakur; Samantha Epstein; Amanda Bilski; Alanna Balbi; Amelia K Boehme; Thomas H Brannagan; Sarah Flanagan Wesley; Claire S Riley
Journal:  Neurology       Date:  2021-09-02       Impact factor: 9.910

Review 5.  Vaccination and anaphylaxis: a forensic perspective.

Authors:  Cristian Palmiere; Camilla Tettamanti; Maria Pia Scarpelli
Journal:  Croat Med J       Date:  2017-02-28       Impact factor: 1.351

Review 6.  Adverse events of vaccines and the consequences of non-vaccination: a critical review.

Authors:  Luana Raposo de Melo Moraes Aps; Marco Aurélio Floriano Piantola; Sara Araujo Pereira; Julia Tavares de Castro; Fernanda Ayane de Oliveira Santos; Luís Carlos de Souza Ferreira
Journal:  Rev Saude Publica       Date:  2018-04-12       Impact factor: 2.106

7.  Methodology for computing the burden of disease of adverse events following immunization.

Authors:  Scott A McDonald; Danielle Nijsten; Kaatje Bollaerts; Jorgen Bauwens; Nicolas Praet; Marianne van der Sande; Vincent Bauchau; Tom de Smedt; Miriam Sturkenboom; Susan Hahné
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-03-24       Impact factor: 2.890

Review 8.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683

Review 9.  Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy.

Authors:  Qinjun Chen; Tao Sun; Chen Jiang
Journal:  Nanomicro Lett       Date:  2021-03-16

10.  A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.

Authors:  Brian P Hanley; Steve Keen; George Church
Journal:  Rejuvenation Res       Date:  2020-06-24       Impact factor: 4.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.